Literature DB >> 12967802

Magnetic resonance imaging measurements of extraocular muscle path shift and posterior eyeball prolapse from the muscle cone in acquired esotropia with high myopia.

Yoshiko Aoki1, Yasuhiro Nishida, Osamu Hayashi, Jiro Nakamura, Sanae Oda, Shinichi Yamade, Kazutaka Kani.   

Abstract

PURPOSE: To investigate extraocular muscle (EOM) path shift and prolapse of posterior eyeball from muscle cone in acquired esotropia with high myopia (AEHM), using magnetic resonance imaging.
DESIGN: A case-control study.
METHODS: There were 16 eyes with AEHM, 11 with high myopia (HM), 12 with moderate myopia (MM), and 11 control eyes. Extraocular muscle shift was evaluated by measuring angles formed by the line connecting orbital centroids and the line connecting each orbital centroid and each EOM centroid. The ratio of the prolapse in the posterior eyeball from the muscle cone was also measured.
RESULTS: Both inferior shift of lateral rectus (LR) and nasal shift of superior rectus (SR) muscle were observed in the AEHM group, compared with HM, MM, and control groups. Neither shifted significantly in the HM group compared with control group. The prolapse ratio in AEHM group was higher than in the HM, MM, and control groups. Greater EOM shifts and eyeball prolapse were observed when the AEHM was more severe, as in esotropia fixus.
CONCLUSIONS: In AEHM, a prolapsing eyeball shifts LR inferiorly and SR nasally; these findings were not observed in high myopia with neither ocular deviation nor restriction. These shifts reduce abduction and supraduction and increase infraduction and adduction in AEHM. The shifts would be predicted to create a hypoesodeviation, which is a common finding in AEHM. Both EOM shifts and superotemporal eyeball prolapse tend to be greater in esotropia fixus.

Entities:  

Mesh:

Year:  2003        PMID: 12967802     DOI: 10.1016/s0002-9394(03)00276-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  12 in total

1.  "Heavy Eye" syndrome in the absence of high myopia: A connective tissue degeneration in elderly strabismic patients.

Authors:  Tina Rutar; Joseph L Demer
Journal:  J AAPOS       Date:  2008-10-18       Impact factor: 1.220

2.  Prevalence and anatomic mechanism of highly myopic strabismus among Japanese with severe myopia.

Authors:  Yoshitaka Nakao; Tohru Kimura
Journal:  Jpn J Ophthalmol       Date:  2014-01-07       Impact factor: 2.447

3.  Intraocular pressure decreases after muscle union surgery for highly myopic strabismus.

Authors:  Shion Hayashi; Miho Sato; Hitomi Miura; Akira Sugano; Mai Yamazaki; Hidetoshi Yamashita
Journal:  Jpn J Ophthalmol       Date:  2014-12-18       Impact factor: 2.447

Review 4.  Recent advances clarifying the etiologies of strabismus.

Authors:  Jason H Peragallo; Stacy L Pineles; Joseph L Demer
Journal:  J Neuroophthalmol       Date:  2015-06       Impact factor: 3.042

5.  Role of magnetic resonance imaging in heavy eye syndrome.

Authors:  C Maiolo; M Fresina; E C Campos
Journal:  Eye (Lond)       Date:  2017-03-31       Impact factor: 3.775

6.  Knobby Eye Syndrome.

Authors:  Joseph L Demer
Journal:  Strabismus       Date:  2017-12-26

7.  Yamada's surgery for treatment of myopic strabismus fixus.

Authors:  Katyanne Dantas Godeiro; David Kirsch; Marcia Keiko Tabuse; Monica Cronemberger
Journal:  Int Ophthalmol       Date:  2008-06-21       Impact factor: 2.031

8.  Divergence insufficiency associated with high myopia.

Authors:  Hiromi Kohmoto; Kenji Inoue; Masato Wakakura
Journal:  Clin Ophthalmol       Date:  2010-12-22

Review 9.  Management of Strabismus in Myopes.

Authors:  Ramesh Kekunnaya; Anjali Chandrasekharan; Virender Sachdeva
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Jul-Sep

10.  SR and LR Union Suture for the Treatment of Myopic Strabismus Fixus: Is Scleral Fixation Necessary?

Authors:  Carol P S Lam; Jason C S Yam; Flora H S Lau; Dorothy S P Fan; C Y Wong; Christopher B O Yu; Winnie W Y Lau
Journal:  Biomed Res Int       Date:  2015-04-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.